
The BactiVac Network awarded £1.15 million by DHSC programmes
The BactiVac Network secures major funding to advance its mission of accelerating vaccine development against bacterial infections affecting LMICs.
- Published: 9 October 2025
Filter
80 results were found based on your search term

The BactiVac Network secures major funding to advance its mission of accelerating vaccine development against bacterial infections affecting LMICs.

Birmingham researchers will join 2025 Nobel Prize winner Professor Shimon Sakaguchi in a research programme to transform treatment of autoimmune diseases.

Researchers discover a circulating protein responsible for disabling the body’s immune response to tumours; bexmarilimab blocks its release

Results of randomised Phase 2 ImmunoTACE trial saw an increase in progression-free survival time for Hepatocellular Carcinoma (HCC) patients.
We welcomed a group of sixth-form students from disadvantaged backgrounds for a week-long immersive STEM experience.

University of Birmingham medical student Nikhil Mistry gained a prestigious top prize at the 2025 Dr Falk Pharma/Guts UK Charity national awards.

The University of Birmingham has been a driving force in understanding Epstein-Barr Virus and its connection with cancer for many years.

The Lister Institute of Preventative Medicine presents Birmingham researchers with their Fellowship awards.